A Course in Medications Use Systems
Chapter	Topic	Reading	Study Ques.	Hand - outs	Lab & Cases
1	Introduction Objectives: (1) Describe magnitude of quality problems in US health care system (2) Describe magnitude of PDRM problem (3) Outline theory of how PDRM happen. (4) Define & distinguish DTP and DRM.	Hepler & Segal, Preventing Medication Errors and Improving Drug Therapy Outcomes (PME-IDO) Preface, Foreword and Ch 1-2 These are 2 of the 3 foundations of the course and very important. Read Berwick, D. A user's guide to the IOM Quality Chasm Report	SQ 1	Lec01	None
2 3	Understanding Adverse Drug Therapy Outcomes Objectives: (1) explain "simple" and "complex" explanation of DRM; (2) explain terminology, e.g., error, latent state;(3) explain the model drawn in Fig. 1, Chap 3	In Ch.10, read the sections that describe DTP and how they are classified. Read Ch. 3 carefully. This is the third foundation Ch. for the course.	SQ 2	Lec02	Case 1 Case 2
4	A Pharmaceutical Care System Objectives: (1) Describe a systematic procedure for managing drug therapy, one patient at a time. (2) Connect this activity to the theory of DRM. How would pharmaceutical care prevent DRM?	Read Ch. 10, A Pharmaceutical Care System. Read Case 3 and think about it as you read the Ch. Pay attention to the steps in the process, how they fit together, how they are documented. Think about how one would recognize DTPs in practice, what kinds of DTPs one would refer to a physician and why.	SQ-3	Lec03	Case 3
5	SOAP; Dialog as a means of monitoring Objective: Describe effective process for obtaining necessary clinical info from patient	Ch 10, especially pp.276-283	SQ-3 items 3c&3d, Montana Case	Lec3A	Case 4
	Principles of Pharmaceutical Care Objectives Critically evaluate the principles. Support each principle with research findings from Ch 3.	Read Ch 8, especially pp. 217-224	SQ-4	Lec04	Case 4
6	People and Purpose in Med. Use Objectives: describe various purposes for medications use; illness (subjective, primary) and disease (objective, secondary) experience; nature of "therapeutic relationship"	Read PME-IOD, Ch. 4.	SQ-5	Lec05	Case 5 Case 5 Instructor Copy
7	The Environments of Medications Use Objective: Introduce managed care concepts and terminology	PME-IOD Chap 12	SQ-6	Lec06 Lec07
8	The Environments of Medications Use General cost containment and cost-shifting strategies	PME-IOD Chap 12-13	SQ-7	Lec08	Case 6
8		PME-IOD Chap 12-13	SQ-8	Lec09	Case 6
9	The Environments of Medications Use General cost containment and cost-shifting strategies	PME-IOD Chap 12-13		Lec10 Lec11	Case 7
10 11	Cost, Access and Quality Describe three traditional dimensions for evaluating health care; discuss interrelationships; describe issues in drug therapy	PME-IOD Chap 5	SQ-10	Lec12	Case 8 *Case 8-A*
12	Medications Use System Performance InformationIntroduce basic tools of systems management: guidelines, indicators, database, standards	PME-IOD Chap7	SQ-11	Lec13	Case 9 Case 10
	Outline of a Med Use System Introduce systems theory as applied to medications management	PME-IDO Chap. 8	SQ-12	Lec14	Case 9 Case 10
13	Medications Management System Objective: Synthesize systems concepts presented earlier to describe a full-scale medications management system	PME-IDO Chap. 11	See Study Questions	Lec15	Case 11 Case 12
14 15	Effects of PCS on Outcomes and Costs Objectives: Further develop theory of pharmaceutical care; review evidence relevant to the theory.	PME-IDO Chap. 9	See Study Questions	Lec16	Case 13
16	Prescribing Improvement Introduce theories of drug choice, describe common attempts to improve prescribing quality & review evidence	PME-IDO Ch 6 (pp 155-170, 178-191)	See Study Questions	Lec17	Case 14
17	Conclusion Course summary; Consider possible ways forward	PME-IDO Chap 14-15 Additional reading (optional) This paper summarizes much of the course and may help you keep sight of the "big picture."	See Study Questions	Lec18